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Short Communication
Validation of Tissue Microarrays for
Immunohistochemical Profiling of Cancer Specimens
Using the Example of Human Fibroblastic Tumors
Axel Hoos,* Marshall J. Urist,†
Alexander Stojadinovic,* Stephen Mastorides,†
Maria E. Dudas,† Denis H. Y. Leung,‡ David Kuo,†
Murray F. Brennan,* Jonathan J. Lewis,* and
Carlos Cordon-Cardo†
From the Departments of Pathology,† Surgery,* and Biostatistics,‡
Memorial Sloan-Kettering Cancer Center, New York, New York
Tissue microarrays allow high-throughput molecular
profiling of cancer specimens by immunohistochem-
istry. Phenotype information of sections from ar-
rayed biopsies on a multitissue block needs to be
representative of full sections, as protein expression
varies throughout the entire tumor specimen. To val-
idate the use of tissue microarrays for immunophe-
notyping, we studied a group of 59 fibroblastic tu-
mors with variable protein expression patterns by
immunohistochemistry for Ki-67, p53, and the retino-
blastoma protein (pRB). Data on full tissue sections
were compared to the results of one, two, and three
0.6-mm core biopsies per tumor on a tissue array.
Ki-67 and p53 staining was read as two categories
(positive or negative). Concordance for this staining
between tissue arrays with triplicate cores per tumor
and full sections were 96 and 98%, respectively. For
pRB staining was read as three categories (high, mod-
erate, or negative), where concordance was 91%. The
use of three cores per tumor resulted in lower num-
bers of lost cases and lower nonconcordance with
standard full sections as compared to one or two
cores per tumor. Correlations between phenotypes
and clinical outcome were not significantly different
between full section and array-based analysis. Tripli-
cate 0.6-mm core biopsies sampled on tissue arrays
provide a reliable system for high-throughput expres-
sion profiling by immunohistochemistry when com-
pared to standard full sections. Triplicate cores offer a
higher rate of assessable cases and a lower rate of
nonconcordant readings than one or two cores. Con-
cordance of triplicate cores is high (96 to 98%) for two
category distinction and decreases with the complex-
ity of the phenotypes being analyzed (91%). (Am J
Pathol 2001, 158:1245–1251)
Tissue microarrays allow for high-throughput molecular
profiling of tissue specimens by several techniques, in-
cluding immunohistochemistry (IHC).1 Standard IHC on
full sections of paraffin-embedded cancer specimens is
useful for identification of molecular markers that predict
patient outcome.2–4 Tissue microarrays may be useful for
investigating a large number of different molecules poten-
tially involved in solid tumor development and/or progres-
sion5 and for determining their role in disease characteriza-
tion and prediction of patient outcome. Currently, limited
data exist on validation of tissue microarrays in breast and
prostate cancer.1,6 It is strongly suggested that tumors with
prominent intratumor heterogeneity need verification of data
generated by tissue microarray analysis.1
The significance of IHC data derived from tissue mi-
croarrays—comprised of small core biopsies of cancer
specimens—relative to full section IHC has not been
clearly determined. Based on the small size of tissue
cores (0.6 mm) taken from paraffin-embedded tumor
specimens heterogeneous expression patterns of inves-
tigated proteins could lead to significant differences in
results between the two techniques. The number of tissue
cores per tumor specimen required on an array to reduce
the error rate attributable to tissue heterogeneity and to
maintain efficient processing of tissues remains to be
determined. It seems reasonable that this error rate may
be reduced by using multiple tissue cores per specimen,
a hypothesis that we tested in this study.
Cut-off values established for full section IHC may not
be useful for assessment based only on a 0.6-mm tissue
sample; eg, Ki-67 nuclear staining in .20% of tumor
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nuclei of full sections is frequently considered to be a
high proliferative index.2 Most standard IHC stains result
in readings that distinguish between positive (1) and
negative (2) categories, whereas others have a higher
degree of complexity requiring the distinction between
three different categories; eg, pRB: high (11), interme-
diate (1), and negative (2). The effect of staining com-
plexity on tissue array-derived data may also lead to
different concordance rates relative to full tissue sections.
In an effort to validate the tissue array technique, we
conducted a study that defined the concordance of sin-
gle, duplicate, and triplicate 0.6-mm core biopsies on
tissue arrays in comparison to full section analysis. We
arrayed a cohort of 59 human fibroblastic tumors known
to have heterogeneous expression of investigated pro-
teins and analyzed abnormalities in expression of Ki-67,
p53, and pRB by IHC. Readings of full sections were
compared with readings of three independent core biop-
sies per specimen sampled on one tissue microarray.
The impact of data discrepancies between the two meth-
ods with regard to patient outcome was also evaluated.
Materials and Methods
Patients
The cohort analyzed consisted of 59 patients with fibro-
blastic neoplasms that included desmoid tumors (n 5
24), low-grade (n 5 21) and high-grade fibrosarcomas
(n 5 14) treated and followed at Memorial Sloan-Ketter-
ing Cancer Center between August 1982 and January
1999. Median age of the cohort was 40 years (range, 10
to 86 years). Median follow-up for the entire group was 36
months. Twenty-seven patients from all three groups de-
veloped local recurrence, whereas 10 fibrosarcoma pa-
tients developed metastasis. At last follow-up 41 patients
had no evidence of disease, eight were alive with dis-
ease, nine died of disease, and one died of other causes.
Recurrence-free and overall survival were defined as
time from primary tumor resection to first recurrence (ei-
ther local or distant) or death from disease, respectively.
Median recurrence-free survival was 18 months and me-
dian overall survival was 35 months.
Tissues, Array Construction, and IHC
Normal and tumor tissues were embedded in paraffin
and five-mm sections stained with hematoxylin and eosin
were obtained to identify viable, morphologically repre-
sentative areas of the specimen from which core biopsies
were taken. This was done with a precision instrument
(Beecher Instruments, Silver Spring, MD) as previously
described.1 From each specimen triplicate tissue cores
with a diameter of 0.6 mm were punched and arrayed on
a recipient paraffin block. Five-mm sections of these tis-
sue array blocks were cut and placed on charged poly-
lysine-coated slides. These sections were used for immu-
nohistochemical analysis.7 Tissues and cell lines known
to express the antigens under study were used as posi-
tive controls. Arrayed normal tissues served as baseline
controls. All normal tissue samples showed physiological
expression patterns of the analyzed markers.
Sections from paraffin-embedded tissue were depar-
affinized, treated with 1% H2O2 in phosphate-buffered
saline, and submitted to antigen retrieval by microwave
oven treatment for 15 minutes in 0.01 mmol/L citrate
buffer at pH 6.0. This procedure was performed for all
antibodies under study. For MIB-1 antibody, an additional
step of incubation in preheated 0.05% Trypsin, 0.05%
CaCl2 in Tris-HCl (pH 7.6) for 5 minutes at 37°C before
microwave treatment was performed. Slides were subse-
quently incubated in 10% normal horse serum for 30
minutes followed by appropriately diluted primary anti-
body incubation overnight at 4°C. Mouse anti-human
monoclonal antibodies to p53 (1:500, Ab-2, clone 1801;
Calbiochem, Cambridge, MA), pRB (1.28 mg/ml; clone
3c8; QED Bioscience, San Diego, CA), and Ki-67 (1:50,
Mib-1; Immunotech, Marseille, France) were used. The
anti-p53 antibody detects wild-type and mutated p53,
whereas the anti-pRB antibody detects normal and hy-
perphosphorylated pRB products (manuscript in prepa-
ration).8 The antibody for Ki-67 recognizes epitopes from
human recombinant peptides of the Ki-67 protein. Sam-
ples were then incubated with biotinylated anti-mouse
immunoglobulins at 1:500 dilution (Vector Laboratories,
Inc., Burlingame, CA) at room temperature for 30 minutes
followed by avidin-biotin peroxidase complexes (1:25,
Vector Laboratories, Inc.) for 30 minutes. Diaminobenzi-
dine was used as the chromogen and hematoxylin as the
nuclear counterstain.
Immunoreactivities were classified as a continuum
data (undetectable levels or 0% to homogeneous stain-
ing or 100%) for all three markers. Slides were reviewed
by three investigators (CCC, AH, MU) and results were
scored by estimating the percentage of tumor cells show-
ing characteristic staining. The cut-off values used in this
study have been shown to be highly sensitive2–4 and
were defined as follows: 1) high proliferative Ki-67 index
if .20% tumor nuclei stained, 2) p53 nuclear overexpres-
sion if .10% tumor nuclei stained. For pRB no cut-off
value was defined. Tumors were then grouped into two
categories defined as follows: normal expression (neo-
plasms below defined cut-off value of immunoreactivity in
tumor cells) and abnormal expression (neoplasms above
defined cut-off values of immunoreactivity in tumor cells).
Validation of Tissue Arrays
Full sections from tumor blocks and sections from the
tissue array containing three representative core biopsies
per tumor block were read in a blinded manner and later
compared to one another. Single readings from each
core were obtained and evaluated as three separate
experiments. Also, cumulative values were established
summarizing the results from two and three core read-
ings. All possible combinations of cores taken from one
specimen were evaluated. Concordance criteria between
full sections and cumulative values of tissue cores were
as follows: if three cores per specimen were available for
reading either three or two cores matching the full section
were sufficient to define the case as a match; if only two
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cores were available for reading both had to match the
full section to define the case as a match.
Two different analyses were performed. First, we sim-
ulated the construction of three tissue arrays containing
either one, two, or three cores per specimen by assem-
bling one tissue array with three physically separated
cores per specimen. We then compared the accuracy of
each of these arrays to the full tissue section. For single
core analysis we excluded cases in which cores were lost
during sectioning and staining. For two and three core
analyses the following case exclusions were made:
cases in which there were two cores available and two
different IHC readings were obtained, cases in which
only one core was available and cases in which all cores
were lost. These were described but not included in the
analysis. All three scenarios were evaluated for numbers
of cases lost from the analysis because of tissue loss or
inconclusive data, and for concordance (percent
matches of evaluated cases). Average values were ob-
tained from three single cores in the one-core analysis
and from the three possible combinations of two cores
per specimen in the two-core analysis. For the triplicate
core analysis all three cores were used to obtain a single
value. This analysis demonstrated the importance of trip-
licate cores to keep numbers of lost cases as low and
concordance rates as high as possible. Second, based
on the first analysis, the specific details of a triplicate core
tissue array were evaluated (summarized in Table 1).
Statistical Analysis
The association between full section analysis and tissue
microarrays was studied using kappa statistics.9 Kappa
values .0.7 were considered to express a strong asso-
ciation between the two methods. Survival analysis was
performed by the method of Kaplan-Meier10 and statisti-
cal significance (P , 0.05) of outcome comparisons were
evaluated using the log-rank test.11
Results
Number of Cores per Specimen
IHC readings from single cores were compared to cumu-
lative values from two and three cores simulating the
situation of tissue arrays constructed with only one core,
two cores, or three cores per tumor specimen. These
were then compared to the full tissue section. Examples
are shown in Figure 1. Numbers of cases lost from the
analysis were either because of tissue loss or inconclu-
sive data coming from two available cores with different
Table 1. Characteristics of a Tissue Microarray Containing Triplicate Cores per Tumor Specimen in Comparison to Full Tissue
Sections
Marker
Assessable
cores
Concordance Triplicate
assessment Overall concordanceNo. cases Match %
Ki-67, n 5 59 FFF 39 FFF 65 Match Total evaluated: 53
n 5 47 6 FFE 10 Match
2 FEE 4 Mismatch
– EEE – Mismatch
FF 6 FF 10 Match Match: 51/53 5 96%
n 5 7 1 FE 2 N/A
– EE – Mismatch
F 3 F 5 N/A
n 5 3 – E – N/A
Lost 2 – 4 N/A
n 5 2
p53, n 5 59 FFF 37 FFF 63 Match Total evaluated: 49
n 5 38 – FFE – Match
– FEE – Mismatch
1 EEE 2 Mismatch
FF 11 FF 18 Match Match: 48/49 5 98%
n 5 11 – FE – N/A
– EE – Mismatch
F 9 F 15 N/A
n 5 9 0 E – N/A
Lost 1 – 2 N/A
n 5 1
pRB, n 5 59 FFF 23 FFF 39 Match Total evaluated: 47
n 5 31 6 FFE 10 Match
1 FEE 2 Mismatch
1 EEE 2 Mismatch
FF 14 FF 23 Match Match: 43/47 5 91%
n 5 17 1 FE 2 N/A
2 EE 4 Mismatch
F 6 F 10 N/A
n 5 6 – E – N/A
Lost 5 – 8 N/A
n 5 5
F, match between tissue array core and full section; E, mismatch between tissue array core and full section; N/A, not assessable.
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Figure 1. Representative photomicrographs of immunophenotypes of Ki-67, p53, and pRB in 59 fibroblastic tumors. A direct comparison between expression
patterns on full tissue sections to the three core biopsies taken from the same tissue block (quarter cores depicted) is shown. Ki-67: Overexpression of Ki-67
nuclear antigen in a fibrosarcoma with consistent distribution of positive tumor nuclei on full section and array. p53: Tumor nuclei in a fibrosarcoma positive for
p53 staining, giving consistent positive readings for full section and array. pRB: Accumulation of hyperphosphorylated pRB in the nuclei of a fibrosarcoma
consistently read as high levels (11) in all four examples. Below a case of heterogeneous expression of pRB characterized by highly positive (11) and
completely negative areas (2) from the same full section (left). Triplicate cores taken from this case were read as moderately positive, representing the normal
phenotype of pRB (1). This is the only case in the analysis of pRB in which all three available readings from the tissue array showed a mismatch compared to
the full section (see Table 1). All photomicrographs are shown at an original magnification of 3400.
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readings. The rates of lost cases for the single core array
were 10, 18, and 25% for Ki-67, p53, and pRB, respec-
tively. These rates were 17, 30, and 37% with two evalu-
ated cores. The rates for two-core analysis include cases
in which both cores were lost as well as cases in which
only one core was lost because the remaining core was
insufficient to reflect the information for both. The combi-
nation of data taken from two experiments had an addi-
tive effect on the number of excluded cases in that anal-
ysis. For three-core analysis these rates were at 10, 17,
and 20%, respectively. The reduced rate of lost cases
was because of the availability of the third core allowing
a majority decision in problematic cases (2 . 1). Dis-
agreements between duplicate cores from one specimen
were more common for two-core analysis (Ki-67, 13%;
pRB, 8%) than for cases from the three-core analysis, in
which one of the three was lost (2% each for Ki-67 and
pRB). This may be attributable to statistical variation. No
such disagreement was seen for p53 because there was
only one mismatch case in that analysis. Nonconcor-
dance (percent mismatches of evaluated cases) was the
lowest for three cores (Ki-67, 3.7%; pRB, 6.4%) versus
two cores (4.4%, 6.5%) and one core alone (9.4%,
11.4%). For p53 these rates were uniformly 2% because
of only one nonconcordant case. Taken together, this
demonstrates the importance of triplicate cores to keep
numbers of lost cases as low and concordance rates as
high as possible. Based on this analysis the specific
details of a triplicate core tissue array were evaluated.
Evaluation of Triplicate Core Tissue Array
Specifics
Ki-67 Proliferative Index
Fifty-three of 59 cases (90%) on the tissue array were
assessable because six cases were excluded because
of tissue loss or inconclusive readings between two
cores. High Ki-67 proliferative index was found in 18 of
these 53 cases (34%) but was not detected in 35 cases
(66%) using standard full-section IHC. In comparison,
high proliferative index was read slightly less frequently
from the tissue array from which 16 cases (30%) were
considered to show overexpression (.20% nuclear stain-
ing) whereas 37 (70%) were read as normal. Overall, the
nonconcordance between full sections and tissue array
was 4% (two cases). In 10% of cases the concordance
was because of two cores displaying the same pattern as
the full section and one core showing a different pattern.
These data demonstrate reliable readings from a tripli-
cate core array in 96% of the assessable cases (Table 1).
The two methods showed a strong statistical association
(kappa value, 0.874).
p53 Nuclear Overexpression
p53 protein half-life is short and expression levels are
low in normal cells and therefore IHC cannot detect these
normal p53 levels. In cancer cells, most p53 mutations
lead to products that are not ubiquitinated, accumulate in
the nuclei, and can be demonstrated by IHC. Because of
tissue loss or inconclusive readings between two cores,
49 of 59 cases (83%) were assessable. Five cases (10%)
showed nuclear staining .10% of tumor nuclei, whereas
44 cases (90%) were negative on full section analysis. In
comparison, four cases (8%) were read as positive and
45 cases as negative (92%) on the array. Overall, the
nonconcordance was 2% (one case) for a concordance
of 98% among the assessable cases (Table 1). A strong
statistical association between full sections and array for
p53 IHC was also demonstrated (kappa value, 0.878).
pRB Expression Patterns
Genetic alterations of RB are either deletions or point
mutations. Patterns of expression of pRB have been clas-
sified as wild type when low nuclear staining is observed
(1), and abnormal when undetectable (because of
genetic deletion/mutation) (2) or when producing high
nuclear staining (mainly because of nonactive, hyper-
phosphorylated proteins) (11). All three phenotypes of
RB were observed in this study and were evaluated as
three categories for the array validation. Because of tis-
sue loss or inconclusive readings between two cores, 47
of 59 cases (80%) were assessable. Twenty-two cases
(47%) were read as abnormal and 25 (53%) as normal
based on full section and tissue array analysis. These
numbers include four mismatches (nonconcordance
9%), two occurring in the abnormal and two in the normal
category, and therefore leading to equal counts in both
categories. A strong statistical association between both
methods was also seen for this stain (kappa value,
0.853). For clinicopathological correlation of data three
category readings were grouped in two functional cate-
gories: normal (wild type) and abnormal (deleted/mu-
tated or hyperphosphorylated) (see below).
Clinicopathological Correlations
To identify differences in clinicopathological correlations
between the data generated with the two methods we
independently analyzed both data sets with regard to
their predictive value for patient outcome. The compari-
son of molecular data to patient outcome displayed a
significant association between recurrence-free and
overall survival and overexpression of Ki-67 if full sections
were used (P 5 0.03, P 5 0.03). These associations
remained significant if the tissue array-derived data were
used (P 5 0.01, P 5 0.01).
Discussion
Tissue microarrays are useful tools for the rapid and
efficient analysis of large numbers of paraffin-embedded
tissues.1 Tissue core biopsies of 0.6-mm diameter are
taken from representative areas of paraffin-embedded
tissues and are arrayed on one recipient block. The di-
ameter of these cores is large enough to assess histo-
morphology and analyze expression of molecules at the
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DNA, mRNA, or protein level.1,12–14 Certain phenotypes
in cancer tissues, analyzed by IHC have been correlated
with patient outcome.2,3,15 Cancer tissues frequently re-
veal heterogeneous expression patterns of investigated
molecules throughout the specimen on standard full sec-
tions. For analysis correlating IHC and clinical data cut-
off values have been established to define the rate of
positive cells relevant to tumor biology.2,3,15 However,
these values are based on assessment of an entire tissue
section encompassing thousands of cells. To facilitate
high-throughput analysis, 0.6-mm core biopsies on tissue
arrays contain only a small fraction of the cells from one
particular tissue block. Our concern was that tissue het-
erogeneity could hinder the ability of tissue arrays to
substitute for full tissue sections. Therefore, we designed
this study to directly compare IHC readings from stan-
dard full sections to a tissue array containing three rep-
resentative and physically separated cores per speci-
men. Independent evaluation of three data sets per
specimen allowed us to simulate the situation of tissue
arrays containing either one, two, or three cores per
specimen.
We used well characterized antibodies against Ki-67
and p53 that require a distinction between two categories
(1 or 2) and a pRB antibody that requires a distinction
between three categories (manuscript in preparation)8
(Figure 1). Thus, we investigated the potential adverse
impact that staining complexity might have on the accu-
racy of IHC data generated from tissue arrays. In addi-
tion, these markers were chosen because of their rele-
vance in human cancer development and our extensive
previous experience.5,7,16 IHC was done on a group of 59
fibroblastic tumors known to show heterogeneous ex-
pression patterns for Ki-67, p53, and pRB.2,3,15,17 Pro-
cessing of tissue sections from both tumor blocks and
arrays was based on previously established protocols as
they can have significant influence on the results (see
Materials and Methods).
Our first analysis comparing one, two, and three cores
per specimen demonstrated a higher number of lost
cases and lower concordance with the full section read-
ing for one or two cores per case in comparison to three
cores. Tissue loss is a significant factor for tissue array-
based analysis with previously reported rates of tissue
damage ranging from 15 to 33%.6,12,13 Our data show
that the presence of a third core reduces the risk of losing
the case because of tissue damage. Nonconcordance
was the lowest for three cores identified as 4, 2, and 9%
for Ki-67, p53, and pRB, respectively. This again shows
the importance of the third core because three cores
allow a majority decision (2 . 1) if one core differs from
the other two. Taken together, three cores provide a
relatively high concordance compared to only one core
and reduce the problems of higher case loss that is seen
with two cores. Thus, three cores per specimen increase
both the accuracy and the strength of array-based data.
Theoretically, accuracy levels would probably rise with
the use of more than three cores per specimen. However,
from a practical point of view it is desirable to identify the
minimal number of cores necessary to obtain highly ac-
curate results from tissue arrays and allow the most eco-
nomic processing of the tissues without the need to array
a larger number of cores per tumor specimen. The high
accuracy achieved with triplicate cores for stains that re-
quire two-category distinction suggests that this may be a
useful setup for routine application of tissue microarrays.
Based on this information we further evaluated the
three-core tissue array. The reduction of assessable
cases because of tissue loss during cutting and transfer
of array sections and vigorous staining procedures or
because of inconclusive data derived from two cores with
different readings was 10, 17, and 20% for Ki-67, p53,
and pRB, respectively. Other groups reported similar or
higher rates of tissue loss.6,12–14 Cases were excluded if
all three cores were lost and if only one core or two cores
with discrepant readings remained. This was done to
eliminate cases that were inconclusive or nonassessable
and thus simulate the situation of a tissue array without
the control of a full section (Table 1).
The concordance between full tissue sections and trip-
licate core arrays for Ki-67, p53, and pRB was 96, 98, and
91%, respectively. These results include 10% of evalu-
ated cases for Ki-67 and pRB for which concordance was
based on the dominant result of two tissue cores match-
ing the full section and one core not matching the full
section (Table 1). This demonstrates the relevance of the
third core for difficult cases. Despite the use of triplicate
cores the nonconcordance for pRB was still 9%. This can
be explained by the complexity of the staining pattern
obtained for pRB requiring a three-category distinction.
Statistically it is less likely to obtain identical readings for
this three-category distinction than for the standard two-
category distinctions used for Ki-67 and p53. This is
clearly reflected by the low nonconcordance of 4 and 2%
for these stains. The nonconcordance of 9% for pRB
suggests that tissue array analysis of pRB or other three-
category markers may not be technically feasible or
readily applicable for clinicopathological analyses.
The few nonconcordant readings that we found,
changed abnormal readings into normal readings and
therefore lead to less frequent detection of abnormal
expression patterns. Full tissue section analysis resulted
in 10, 34, and 47% of cases in detection of abnormal
expression of p53, Ki-67, and pRB, respectively. Corre-
sponding rates of expression on the triplicate core tissue
array were 8, 30, and 47%, respectively. These concor-
dances suggest that triplicate cores on tissue arrays
accurately reflect IHC results from full section analysis.
This is supported by strong statistical associations be-
tween the two methods with kappa values of .0.853.
In this context, it must be emphasized that the selec-
tion of areas on hematoxylin and eosin-stained full sec-
tions from tissue blocks based on tumor morphology are
crucial for the assembly of a tissue array. This requires
meticulous attention of the investigator before the array is
constructed and data are evaluated. Thus, it is ensured
that the resulting arrays potentially provide relevant infor-
mation about tumor-specific immunophenotypes.
To identify potential changes in outcome correlations
caused by differences between the two techniques we
compared survival data with the two data sets obtained
by full tissue sections and tissue arrays and analyzed for
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local recurrence-free survival and overall survival. As
suggested by the strong association between the two
methods no differences were detected in correlation on
the basis of patient outcome. This suggests that tissue
arrays will allow reliable clinicopathological analysis of
tumor specimens. This observation is based on a rela-
tively small cohort of patients (n 5 59) that permits limited
conclusions about the applicability of tissue microarrays
for clinicopathological studies. However, the strong as-
sociation between the two methods and the fact that even
full section analysis often represents only a small portion
of the whole tumor specimen but still allows identification
of clinicopathologically relevant immunophenotypes is
promising. Therefore, we believe that tissue microarray-
derived data will be useful for clinicopathological studies.
In summary, our data demonstrate a high reliability of
tissue array-based IHC using standard cut-off values
established for full section analysis. The use of three
tissue cores is preferable to one or two cores and IHC
stains with two-category distinction should be preferred
over more complex stains where possible. Such triplicate
core biopsies of 0.6-mm diameter taken per specimen
provide a reliable system for large-scale analysis of can-
cer tissues on tissue microarrays without compromising
the efficiency of the array technology and may be useful
tools for clinicopathological analysis.
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